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Objective: High body mass index (BMI) is associated with increased risk of osteoarthritis (OA) and
reduced risk of fragility fracture. However, the relationship between fragility fracture and OA remained
unclear. This study sought to investigate the effect of bone mineral density (BMD) in the OA-fracture
relationship.
Methods: Data from 2412 women and 1452 men aged >45 years in the Dubbo Osteoporosis Epidemi-
ology Study (DOES) were analyzed. Individuals have been followed for up to 22 years (median: 7.5 years;
range: 0.1e22 years). Femoral neck BMD (FNBMD) and lumbar spine BMD (LSBMD) was measured by
dual energy X-ray absorptiometry (DXA) (GE LUNAR, Madison, WI). The presence of OA was ascertained
at baseline by self-reported diagnosis. The incidence of low-trauma fracture was ascertained from X-ray
reports.
Results: Overall, 29% of women and 26% of men had reported a diagnosis of OA. Fracture risk was
signiﬁcantly higher in women with OA than those without OA (Hazard ratio (HR) ¼ 1.50; 95% conﬁdence
interval (CI), 1.28e1.76). However, the association was mainly observed in women with osteopenic BMD
(HR ¼ 1.74; 95% CI, 1.38e2.17) and normal-BMD (HR ¼ 1.50; 95% CI, 1.06e2.13) and not in those with
osteoporosis. Further analysis revealed that osteopenic womenwith OA had signiﬁcant increase in risk of
vertebral (HR ¼ 1.85; 95% CI, 1.24e2.75) and limb fracture (HR ¼ 2.49; 95% CI, 1.77e3.48), but not in hip
fracture. In men, no comparable relationship was found before and after adjustment for covariates.
Conclusion: Women with OA have an increased risk of fragility fracture, and the risk was mainly
observed in non-osteoporotic group.
© 2014 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.Introduction
Osteoarthritis (OA) and fragility fracture due to osteoporosis
impose signiﬁcant health burden in the elderly population.
Approximately 30% of people aged over 65 have radiographic evi-
dence of OA1. Globally, OA is the sixth leading disabling condition
which accounts for nearly 3% of total global years of living with
disability2. Fragility fracture risk also increases with advancing age.o: T.V. Nguyen, Division of
Research, 384 Victoria Street,
x: 61-2-9295-8241.
yen).
ternational. Published by Elsevier LThe residual lifetime risk of fragility fracture is 44% in women and
30% in men aged 60 and above3. Although the prevalence of these
two conditions is high, their association has not been well
documented.
The etiology of OA is complex, but several risk factors have been
identiﬁed to be associated with the disease. High body mass index
(BMI) is a well-recognized risk factor for both the onset4e6 and
progression of OA7,8. High bonemineral density (BMD) is also found
to be associated with greater risk of OA at the knee and hip9e11.
However, it is unclear whether OA, with its link to greater bone
density, could be translated into a reduced risk of fragility fracture.
The relationship between OA and fragility fracture was ﬁrst re-
ported in 1972, based on the observation that OA seldom co-existedtd. All rights reserved.
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assumed that OA is a protective factor against fragility fracture13e15.
An earlier study has reported that hip fracture risk was 62% lower in
the OA cases compared to the controls13. However, several recent
studies have suggested that the incidence of fracture was higher in
those with than without OA16e18. For example, in the Women's
Health Initiative (WHI) study, the risk of any fracture and spine
fracture were increased by 1.1-fold and 1.2-fold, respectively, in
subjects with self-reported OA18. A study of 6641 men and women
also found a signiﬁcant increase in non-vertebral fracture risk in
patients with knee OA17. Although it has been suggested that the
increased fracture risk in patients with OA was attributed to their
higher tendency of falling17,19,20, there is evidence that greater risk
of falls did not fully explain the higher fracture incidence in the OA
population16e18. BMD is a robust predictor of fracture risk, but it is
not known whether BMD is an intermediary in the OA-fracture
relationship. Hence, we sought to examine the effect of BMD on
the association between OA and fracture risk in both men and
women.
Methods
Participants and setting
This study is part of the on-going Dubbo Osteoporosis Epide-
miology Study (DOES), a population-based prospective study
commenced in 1989 in the city of Dubbo about 400 km northwest
of Sydney, Australia. The Dubbo population, at that time, was
~32,000 and had expanded to ~41,000 by 2009. Full details of the
population and study design have been described elsewhere21.
Initially, the study population of DOES project was comprised of
~1600 men and 2095 women aged 60 years with 98.6% of
Caucasian origin. Recruitment has been extended to include those
who were older than 18 year of age since early 1990s. However, the
selection criteria for the present study were restricted to those
participants who were older than 45 and free of rheumatoid
arthritis, malignancy or metabolic bone diseases. As a result, 2412
women and 1452 men recruited between 1989 and 2011, who had
been followed for a median of 7.5 years (range 0.1e22 years), were
included in the ﬁnal analysis. This study was approved by the St
Vincent's Hospital Ethics committee and written informed consent
was obtained from all participants.
Bone measurements and risk factors assessment
BMD was measured at the femoral neck and lumbar spine by
dual energy X-ray absorptiometry (DXA), using GE LUNAR DPX-L
and later PRODIGY densitometer (GE LUNAR, Madison, WI, USA).
The radiation dose used is less than 0.1 mGy and the coefﬁcient of
variation of BMD at our laboratory is 1.5% for lumbar spine and 1.3%
for femoral neck22,23.
Body weight (kg) was measured in light clothing and without
shoes using an electronic scale. Height (cm) was measured without
shoes by a wall-mounted stadiometer. (BMI, kg/m2) was calculated
based on the weight and height measured at baseline. Other
anthropometric variables, history of falls, smoking, physical activity
level, uses of glucocorticoid, hormonal replacement therapy (HRT)
were obtained via a structured questionnaire administered by a
trained nurse during the interviews at baseline and biennial follow-
up visits.
OA ascertainment
The presence of OAwas based on self-reporting and recorded in
the questionnaires during the baseline interview. Participants wereasked if they had ever had arthritic diseases. In the case of an
afﬁrmative answer, further questions were asked to clarify the type
of arthritic disease andwhether they had beenmedically diagnosed
or treated for the conditions. Those who had been diagnosed as OA
by their clinicians were referred as “OA cases”.Fracture ascertainment
Incident fracture occurring during the study period were iden-
tiﬁed through radiologists' reports from two to three radiology
centers within the Dubbo region as previously described22. Only
those resulting from low-energy trauma such as falls from standing
height or less were included in this analysis. Fractures due to ma-
lignant diseases or high impact trauma (e.g., motor vehicle acci-
dent, sport injury or fall from above standing height) were
excluded. Vertebral fractures were clinically diagnosed. No sys-
temic X-ray screening for asymptomatic vertebral fracture was
conducted prior to the study.Data analysis
Descriptive analyses were performed using Student's t test for
continuous variables and chi-square tests for categorical variables.
Cox's proportional hazard regression was used to assess the
strength of association between OA and any fracture risk, with
time to fracture being the outcome. Hazard ratios (HR) with 95%
conﬁdence intervals (CI) were computed in the presence of OA
before and after adjustment for potential confounders (i.e., age,
falls, prior fracture, glucocorticoid use, smoking, physical activity
and HRT). The full model was selected through stepwise backward
algorithm with minimum Akaike information criterion (AIC)
values and the chosen covariates are all known to be associated
with fracture risk. The proportional hazard assumption was tested
by regression of the Schoenfeld residuals for each covariate against
time to determine the independence between residuals and
time24. No signiﬁcant relationship between residuals and time was
found in any of the covariates involved. Subgroup analyses were
performed on individual BMD (i.e., osteoporotic, osteopenic and
normal-BMD) and BMI subgroups (i.e., normal-BMI ¼ BMI < 25 kg/
m2; overweight ¼ BMI 25e29 kg/m2; obese ¼ BMI  30 kg/m2).
The areas under the receiver operating characteristic (ROC) curve
(AUCs) were used to assess the models' performance with and
without inclusion of OA, in terms of their discriminatory ability of
fracture cases. Both models were adjusted for age, falls, FNBMD,
prior fracture, smoking, glucocorticoid use, physical activity level,
and HRT (in women). Net reclassiﬁcation improvements (NRIs)
were calculated, using the reclassiﬁcation method25, to quantify
the level of improvement with the inclusion of OA. Participants
were classiﬁed into three risk groups (i.e., low risk, medium risk
and high risk group) based on their absolute 10-year risk of frac-
ture for the model with OA and the model without OA included.
The cut-off values were chosen according to the distribution of
fracture risk in the study population (i.e., lower, middle and upper
tertiles) so as to have a comparable sample size for each of the
three groups. The difference in proportion of those with and those
without fracture moving up or down risk category was calculated
as follows:
NRI ¼ ½PrðupjcasesÞ  PrðdownjcasesÞ  ½PrðupjcontrolÞ
 PrðdownjcontrolsÞ
where Pr stands for probability. All statistical analyses were per-
formed using the R program, version R 2.15.2, for Windows26.
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Baseline characteristics
Overall, 33% of women and 18% of men sustained at least one
fragility fracture during the follow-up period. As expected, in-
dividuals with OA were older and had higher body weight, BMI,
FNBMD and LSBMD, compared with those without OA. The
incidence of falls in the past 12 months was signiﬁcantly higher
in the OA group than the non-OA group. Women with OA were
less likely to receive HRT; whereas, men with OA were more
likely to be current or past smokers compared to their non-OA
counterparts. However, no signiﬁcant difference in physical ac-
tivity level and glucocorticoid use was found between the two
groups (Table I).Fig. 1. Prevalence of OA for different (a) BMI and (b) BMD groups in women and men.OA and fracture risk
At baseline, 29% of women and 26% of men reported a diagnosis
of OA. As expected, prevalence of OA increased with each higher
BMI and BMD category (Fig. 1). In women, the presence of OA had
signiﬁcantly increased the risk of any fracture (HR ¼ 1.50; 95% CI,
1.28e1.76), hip (HR¼ 1.87; 95% CI,1.34e2.62), vertebral (HR¼ 1.68;
95% CI, 1.28e2.21) and limb fracture (HR ¼ 1.88; 95% CI, 1.48e2.38).
After adjusting for age, the association between OA and fracture
risk inwomen remained signiﬁcant for any fracture (HR¼ 1.28; 95%
CI, 1.09e1.50), vertebral (HR ¼ 1.32; 95% CI, 1.01e1.74) and limb
fracture (HR ¼ 1.67; 95% CI, 1.33e2.16), but not for hip fracture.
Similar results were observed when BMI or BMD was included in
the model. Further adjustment for clinical risk factors (age, falls,
prior fracture, smoking, physical activity, glucocorticoid use and
HRT) did not alter the results signiﬁcantly. In men, there was no
signiﬁcant association between OA and fracture risk at all skeletal
sites examined, before and after adjustment for covariates (Table II).Table I
Characteristics of the study population
Non-OA OA
Women n ¼ 1721 n ¼ 691
Age (years) 67.46 (8.50) 69.25 (7.10)***
Weight (kg) 66.93 (13.47) 71.70 (14.45)***
Height (cm) 160.30 (6.41) 159.93 (6.07)
BMI (kg/m2) 26.02 (4.95) 28.02 (5.46)***
FNBMD (g/cm2) 0.82 (0.15) 0.85 (0.14)**
LSBMD (g/cm2) 1.06 (0.19) 1.10 (0.21)***
Fracture incidence (%) 31.61 (n ¼ 544) 37.88 (n ¼ 261)**
Fall in last 12 months (%) 32.02 (n ¼ 551) 38.49 (n ¼ 266)**
Physical activity index (MET) 30.82 (3.08) 30.38 (2.67)
Glucocorticoid use (%) 7.67 (n ¼ 132) 7.81 (n ¼ 54)
HRT (%) 10.05 (n ¼ 173) 8.68 (n ¼ 60)***
History of smoking (%) 32.01 (n ¼ 551) 30.54 (n ¼ 211)
Median follow-up time (year) 7.47 7.42
Men n ¼ 1066 n ¼ 386
Age (years) 67.95 (7.54) 69.32 (6.76)***
Weight (kg) 80.20 (13.81) 84.12 (13.64)***
Height (cm) 173.57 (6.92) 173.45 (6.59)
BMI (kg/m2) 26.56 (3.93) 27.92 (4.03)***
FNBMD (g/cm2) 0.92 (0.15) 0.95 (0.15)***
LSBMD (g/cm2) 1.24 (0.21) 1.32 (0.22)***
Fracture incidence (%) 18.86 (n ¼ 201) 16.58 (n ¼ 64)
Fall in last 12 months (%) 22.80 (n ¼ 243) 26.68 (n ¼ 103)**
Physical activity index (MET) 33.27 (5.55) 32.88 (5.18)
Glucocorticoid use (%) 7.41 (n ¼ 79) 5.67 (n ¼ 22)
History of smoking (%) 59.19 (n ¼ 631) 65.28 (n ¼ 252)*
Median follow-up time (year) 7.39 7.55
Values are means (SD) unless speciﬁed otherwise; *P < 0.05; **P < 0.01; ***P < 0.001.OA and fracture risk by BMD
The incidence rates of fracture were consistently higher in
women with OA rather than without OA across all BMD groups
[Fig. 2(a)]. However, the association between OA and fracture risk
was only signiﬁcant in women with osteopenia or normal-BMD,
and not in those with osteoporosis. The unadjusted HR of any
fracture for OA were 1.02 (95% CI, 0.73e1.43), 1.63 (95% CI,
1.31e2.01) and 1.58 (95% CI, 1.15e2.20) in osteoporotic, osteopenic
and normal-BMD women, respectively. Further adjustment for
clinical risk factors yielded similar associations (Table III). The risk
of hip fracture was not signiﬁcantly associated with OA after
adjusted for confounders, regardless of the BMD status. On the
other hand, the adjusted risk of vertebral and limb fracture were
signiﬁcantly increased by 1.9-fold (95% CI, 1.24e2.75) and 2.5-fold
(95% CI, 1.77e3.48) respectively, with the presence of OA in
osteopenic women; but not in those with osteoporotic and normal-
BMD (Table III).
In men, the fracture incidence rates were not much different
between OA and non-OA groups for those with osteopenic and
normal-BMD [Fig. 2(b)], and no signiﬁcant association was found
between OA and risk of any fracture, hip, vertebral and limb frac-
ture (Table III). Although men with osteoporosis appeared to have
lower fracture incidence rate among those with OA (39%) than
thosewithout (42%) [Fig. 2(b)], the associations were not signiﬁcant
before and after adjusting for covariates (Table III).OA and fracture risk by BMI categories
The association between OA and fracture risk was assessed for
each BMI subgroup (i.e., normal-BMI, overweight and obese) as
shown in Table III. In men, OA was not a signiﬁcant predictor of
fracture risk in any of the BMI category or fracture type. However, a
signiﬁcant increase in risk of any fracture was observed in OA
women across all BMI categories. The presence of OA was
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Table II
Association between OA and fracture risk before and after adjustment for covariates in women and men
HR (95% CI)
Women Men
Any fracture
(n ¼ 805)
Hip fracture
(n ¼ 178)
Vertebral fracture
(n ¼ 274)
Limb fracture
(n ¼ 353)
Any fracture
(n ¼ 265)
Hip fracture
(n ¼ 59)
Vertebral fracture
(n ¼ 99)
Limb fracture
(n ¼ 107)
OA (unadjusted) 1.50 (1.28e1.76) 1.87 (1.34e2.62) 1.68 (1.28e2.21) 1.88 (1.48e2.38) 0.81 (0.61e1.07) 1.00 (0.57e1.77) 0.82 (0.52e1.29) 0.71 (0.45e1.12)
OA (adjusted for age) 1.28 (1.09e1.50) 1.29 (0.92e1.81) 1.32 (1.01e1.74) 1.67 (1.33e2.16) 0.94 (0.69e1.28) 1.06 (0.57e1.95) 0.97 (0.59e1.61) 0.87 (0.52e1.46)
OA (adjusted for age, BMI) 1.29 (1.10e1.51) 1.38 (0.98e1.93) 1.33 (1.01e1.75) 1.70 (1.32e2.16) 0.96 (0.70e1.29) 1.09 (0.60e2.01) 0.98 (0.60e1.62) 0.88 (0.52e1.46)
OA (adjusted for age, FNBMD) 1.35 (1.15e1.59) 1.36 (0.97e1.92) 1.43 (1.09e1.89) 1.81 (1.42e2.31) 1.02 (0.75e1.38) 1.19 (0.65e2.18) 1.09 (0.66e1.79) 0.92 (0.55e1.54)
OA (adjusted for age, LSBMD) 1.35 (1.15e1.58) 1.45 (1.04e2.03) 1.52 (1.15e2.00) 1.81 (1.42e2.30) 1.06 (0.78e1.44) 1.23 (0.66e2.27) 1.17 (0.71e1.94) 0.96 (0.57e1.61)
OA (adjusted for age, BMI and
clinical risk factors)
1.38 (1.17e1.63) 1.38 (0.97e1.94) 1.45 (1.08e1.94) 1.87 (1.44e2.42) 1.01 (0.73e1.39) 1.16 (0.62e2.17) 0.93 (0.56e1.59) 0.94 (0.55e1.62)
OA (adjusted for age, FNBMD
and clinical risk factors)
1.43 (1.21e1.68) 1.35 (0.95e1.91) 1.59 (1.19e2.12) 1.96 (1.52e2.53) 1.05 (0.77e1.45) 1.27 (0.67e2.39) 1.04 (0.61e1.75) 0.97 (0.56e1.66)
OA (adjusted for age, LSBMD
and clinical risk factors)
1.45 (1.23e1.71) 1.47 (1.04e2.07) 1.68 (1.26e2.24) 2.01 (1.56e2.61) 1.13 (0.82e1.56) 1.37 (0.72e2.61) 1.19 (0.70e2.02) 1.03 (0.59e1.77)
Clinical risk factors included falls in the past 12 months, prior fracture after age 50, history of smoking, glucocorticoid use, physical activity level and HRT (in women); bold-faced letters are statistically signiﬁcant.
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Table III
Association between OA and fracture risk as stratiﬁed by BMD and BMI groups in women and men
HR (95% CI)
Any fracture Hip fracture Vertebral fracture Limb fracture
OA unadjusted OA multivariate
adjustment
OA unadjusted OA multivariate
adjustment
OA unadjusted OA multivariate
adjustment
OA unadjusted OA multivariate
adjustment
Women
BMD groups
Osteoporotic 1.02 (0.73e1.43) 1.06 (0.75e1.50) 1.53 (0.95e2.48) 1.38 (0.84e2.29) 0.81 (0.41e1.58) 1.06 (0.51e2.17) 1.05 (0.53e2.08) 1.28 (0.61e2.69)
Osteopenic 1.63 (1.31e2.01) 1.74 (1.38e2.17) 1.69 (1.02e2.81) 1.47 (0.87e2.48) 1.94 (1.33e2.83) 1.85 (1.24e2.75) 2.20 (1.62e2.98) 2.49(1.77e3.48)
Normal-BMD 1.58 (1.15e2.20) 1.50 (1.06e2.13) 1.68 (0.52e5.41) 1.41 (0.43e4.63) 2.07 (1.25e3.44) 1.44 (0.82e2.50) 1.59 (1.00e2.53) 1.41 (0.86e2.31)
BMI groups
Normal-BMI 1.50 (1.15e1.93) 1.29 (1.01e1.65) 2.29 (1.50e3.53) 1.47 (0.93e2.31) 1.55 (0.99e2.43) 1.33 (0.84e2.13) 1.97 (1.34e2.89) 1.80 (1.19e2.72)
Overweight 1.49 (1.14e1.94) 1.46 (1.10e1.94) 1.41 (0.69e2.86) 1.33 (0.64e2.78) 1.83 (1.17e2.84) 1.38 (0.85e2.25) 1.80 (1.23e2.61) 2.05 (1.35e3.09)
Obese 1.73 (1.22e2.46) 1.47 (0.98e2.19) 2.22 (0.93e5.24) 1.44 (0.54e3.84) 1.94 (1.09e3.44) 2.11 (1.04e4.29) 2.08 (1.24e3.50) 1.59 (0.88e2.87)
Men
BMD groups
Osteoporotic 0.45 (0.18e1.14) 0.39 (0.15e1.03) 0.78 (0.22e2.71) 0.76 (0.20e2.95) 0.23 (0.03e1.76) 0.20 (0.02e1.62) 0.28 (0.04e2.15) 0.19 (0.02e1.56)
Osteopenic 1.26 (0.83e1.92) 1.23 (0.78e1.95) 1.59 (0.68e3.72) 1.36 (0.55e3.35) 1.36 (0.67e2.76) 1.26 (0.59e2.69) 1.28 (0.64e2.56) 1.29 (0.61e2.75)
Normal-BMD 1.43 (0.86e2.39) 1.18 (0.69e2.03) 2.06 (0.58e7.26) 2.12 (0.58e7.79) 1.89 (0.86e4.16) 1.46 (0.62e3.48) 1.03 (0.45e2.37) 0.91 (0.38e2.12)
BMI groups
Normal-BMI 0.94 (0.50e1.41) 0.73 (0.42e1.23) 1.08 (0.41e2.81) 0.91 (0.34e2.45) 1.08 (0.50e2.32) 0.79 (0.36e1.76) 0.58 (0.21e1.62) 0.48 (0.17e1.39)
Overweight 1.13 (0.71e1.80) 1.06 (0.64e1.72) 1.71 (0.71e4.12) 1.44 (0.56e3.72) 0.97 (0.43e2.22) 0.93 (0.39e2.25) 1.13 (0.54e2.35) 1.15 (0.53e2.51)
Obese 2.51 (0.25e5.03) 2.41 (0.17e5.41) 3.62 (0.49e26.6) 4.99 (0.53e47.1) 3.04 (0.42e9.06) 2.45 (0.69e8.62) 2.26 (0.80e6.38) 1.89 (0.52e6.86)
Multivariate adjustment: adjusted for age, falls in the past 12 months, prior fracture after age 50, history of smoking, glucocorticoid use, physical activity level, HRT (in
women); bold-faced letters are statistically signiﬁcant.
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reclassiﬁcation improvement (NRI) with the inclusion of OA in the
predictive model in women (Table IV). In men, no signiﬁcant
improvement in fracture identiﬁcation was noted after OA was
added to the models (AUC: 0.71 vs 0.70; NRI: 0.17%).Discussion
The relationship between OA and fracture risk remains contro-
versial with conﬂicting results reported. So far, few data areTable IV
Comparison of NRI between models with and without OA inclusion across different
absolute risk tertile groups in women
Model without OA Model with OA NRI
Low risk Medium risk High risk
Women
Fracture group
Low risk 107 20 0 1.7%
Medium risk 14 226 32
High risk 0 24 382
Non fracture group
Low risk 625 19 0 4.0%
Medium risk 63 467 24
High risk 0 44 365
Total 5.7%
Men
Fracture group
Low risk 43 0 0
Medium risk 0 75 0 0%
High risk 0 0 147
Non fracture group
Low risk 455 2 0
Medium risk 0 405 2 0.17%
High risk 0 2 321
Total 0.17%
All models included age, FNBMD, falls in the past 12 months, prior fracture after age
50, history of smoking, glucocorticoid use, physical activity level and HRT.available regarding the effect of BMD on the OA-fracture relation-
ship. In this prospective study, we show that the relationship be-
tween OA and fracture risk is not only gender-speciﬁc, but also
BMD-dependent. We found that OA was a signiﬁcant risk factor
for any fracture in women with osteopenia and normal-BMD, but
not in men or osteoporotic women. This is partly in line with the
Rotterdam Study, in which knee OA patients with high BMD had
greater and signiﬁcant risk of non-vertebral, hip and wrist fracture
compared to the low BMD group16. We further demonstrated that
the adjusted associations betweenOA and risk of vertebral and limb
fracture were signiﬁcant only in osteopenic women, suggesting
that BMD is a potential mediator in the OA-fracture relationship.
Consistent with many previous ﬁndings27e29, we also observed
a signiﬁcantly higher baseline BMD in OA patients. However, the
increase in BMD did not translate into a reduction in fracture risk in
both sexes, and this ﬁnding is consistent with previous data18,19,30.
Interestingly, after stratiﬁed by BMD, it was revealed that 23% of
women and 22% of men with osteoporosis had self-reported OA.
Such ﬁndings are also in linewith a recent study on severe knee and
hip OA, which showed 23% of the patients to be osteoporotic and
43% to be osteopenic31. A study on advanced hip OA also found 25%
of OA patients with occult osteoporosis32, suggesting that there is
some overlap between osteoporosis and OA.
Individuals with OA tend to have greater bone loss over time
than their non-OA counterparts33e35. In a study of 3000 elderly
men and women, radiographic hip OA was associated with an
annual bone loss of 2% in men and 1.4% in women, despite 3e8%
higher BMD values comparedwith controls33. Similar bone loss was
also found in metacarpal OA, particularly at the cortical region34.
Since not all OA cases, as shown by our study, have normal or high
initial BMD, further bone loss in these patients will be detrimental
to their bone health and would signiﬁcantly increase their likeli-
hood of subsequent fractures.
Other potential factors contributing to the increased fracture
risk in OA patients could be related to bone structure and bone
quality of the affected joints. A previous in vitro study showed that
not only was trabecular bone volume lower in subjects with OA, but
also trabecular separation was wider compared with normal
M.Y. Chan et al. / Osteoarthritis and Cartilage 22 (2014) 1251e12581256controls36. Furthermore, in comparison to the osteoporotic bones,
those obtained from patients with OA were observed to have
signiﬁcantly higher cortical porosity37; and their material proper-
ties were inferior to both normal and osteoporotic bones38.
The association between OA and fracture risk could also be
related to the higher tendency of falling in OA patients, possibly due
to postural instability, quadriceps weakness, joint pain and stiff-
ness16,19,20. In accordance with previous studies18e20, our data also
demonstrated a signiﬁcantly higher prevalence of falls in women
with OA (39%) compared with those without OA (32%). Neverthe-
less, when history of falls was taken into account in the regression
models, the associations between OA and fracture risk were
attenuated but remained signiﬁcant; suggesting that increased risk
of falling, may have played some part, but it alone could not fully
explain the OA-fracture relation.
In the present study, the association between OA and fracture
risk was only signiﬁcant in women but not in men. Although it is
not clear what constituted the gender-related difference, it is
possible that the low number of fracture case in men may reduce
the statistical power to detect an association. However, we noticed
that the BMD measurements of men were, on average, higher than
that of women. Also, the percent of OA men in the higher BMD
categories were greater than that of OAwomen, suggesting that the
gender-related difference in the OA-fracture relation could be a
result of the intrinsic differences in bone biology between the two
sexes. This is supported by a recent observation that age-related
loss of bone density39 and bone strength loss40 were signiﬁcantly
higher in women compared to men.
The ﬁndings of this study have important clinical implications.
Although low BMD is a major determinant of fragility fracture,
more than 50% of the fracture cases did not have osteoporotic
BMD22. Our ﬁnding of higher fracture incidence in OA individuals
with normal or osteopenic BMD may provide some insight into the
development of non-osteoporotic fragility fracture. At present, the
Garvan fracture risk calculator and the fracture risk assessment tool
(FRAX) are the most commonly used models for fracture risk
assessment, but neither of them has included OA as a risk factor.
Our data suggest that inclusion of OA in fracture risk assessment
may help to improve the identiﬁcation of at-risk individuals,
particularly women without low BMD. More importantly, patients
with OA should not be overlooked for fracture risk assessment and
preventive intervention. However, whether current anti-fracture
treatments, which were primarily targeted at low BMD, will be
appropriate for use in patients with OA has yet to be determined.
The strengths of the present study are the large sample size and
its long duration of follow-up period. Our ﬁndings are derived from
the community-dwelling population and prospective data, and
hence, are less likely subjected to the potential biases inherent in
the volunteer-based and cross-sectional studies. However, a num-
ber of weaknesses should be taken into account in the interpreta-
tion of the ﬁndings. Since the ascertainment of OA was dependent
on self-reported information, we cannot rule out the possibility of
underestimation regarding the number of OA cases. However, the
reliability of case-assignment, in this study, was supported by the
ﬁnding that individuals with OA were both older and had higher
body weight, the two major determinants of OA. Moreover, nearly
all of the OA cases were receiving some form of medical treatment
(including non-steriodal anti-inﬂammatory therapy and surgical
intervention), suggesting the presence of OA symptoms. Besides,
previous studies have shown high reproducibility using self-
reported method14,41. Indeed, a concordance rate of more than
80% has been reported between self-reported OA and clinically
diagnosed OA42. In a separate study, 90% of the self-reported cases
were able to be validated by their correspondingmedical records or
radiographic evidences43. Another limitation is that the deﬁnitionof OA was not site-speciﬁc due to insufﬁcient sample size to
perform further stratiﬁcation. Moreover, the majority of the OA
cases reported had involved more than one joint, making it difﬁcult
to obtain an accurate classiﬁcation. Finally, the present study is
based on a population mainly of Caucasian background and aged
above 45 years, and therefore, its ﬁndings may not be readily
applicable to other populations with different ethnicity and age
structures.
In conclusion, OA is a risk factor for fracture in women, and this
risk was observed predominantly in non-osteoporotic women. This
ﬁnding highlights the importance of considering OA as a risk factor
in fracture risk assessment in clinical setting.
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